| Does treatment delay affect survival in non-small cell lung cancer? A retrospective analysis from a single UK centre H Bozcuk, C Martin Lung cancer 34 (2), 243-252, 2001 | 157 | 2001 |
| Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy H Bozcuk, G Uslu, M Samur, M Yıldız, T Özben, M Özdoğan, M Artaç, ... Cytokine 27 (2-3), 58-65, 2004 | 122 | 2004 |
| “Do not tell”: what factors affect relatives’ attitudes to honest disclosure of diagnosis to cancer patients? M Ozdogan, M Samur, HS Bozcuk, E Coban, M Artac, B Savas, A Kara, ... Supportive care in cancer 12, 497-502, 2004 | 118 | 2004 |
| Does awareness of diagnosis make any difference to quality of life? Determinants of emotional functioning in a group of cancer patients in Turkey H Bozcuk, V Erdoğan, C Eken, E Çıplak, M Samur, M Özdoğan, B Savaş Supportive care in cancer 10, 51-57, 2002 | 100 | 2002 |
| A comparative study of art therapy in cancer patients receiving chemotherapy and improvement in quality of life by watercolor painting H Bozcuk, K Ozcan, C Erdogan, H Mutlu, M Demir, S Coskun Complementary therapies in medicine 30, 67-72, 2017 | 91 | 2017 |
| Factors associated with utilization of nonproven cancer therapies in Turkey: a study of 135 patients from a single center M Samur Supportive care in cancer 9, 452-458, 2001 | 87 | 2001 |
| Factors related to truth-telling practice of physicians treating patients with cancer in Turkey M Ozdogan, M Samur, M Artac, M Yildiz, B Savas, HS Bozcuk Journal of palliative medicine 9 (5), 1114-1119, 2006 | 81 | 2006 |
| Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published randomized controlled trials H Bozcuk, M Artac, M Ozdogan, B Savas Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 75 | 2005 |
| Platelet to lymphocyte ratio as a new prognostic for patients with metastatic renal cell cancer S Gunduz, H Mutlu, D Tural, Ö Yıldız, M Uysal, HS Coskun, H Bozcuk Asia‐Pacific Journal of Clinical Oncology 11 (4), 288-292, 2015 | 70 | 2015 |
| Hope in people with cancer: a multivariate analysis from T urkey ST Kavradim, ZC Özer, H Bozcuk Journal of advanced nursing 69 (5), 1183-1196, 2013 | 65 | 2013 |
| Does music exposure during chemotherapy improve quality of life in early breast cancer patients? A pilot study H Bozcuk1ABCDEF, M Artac1ABDF, A Kara2B, M Ozdogan1BD, ... Med Sci Monit 12 (5), 205, 2006 | 59 | 2006 |
| Durable remission of leptomeningeal metastasis of breast cancer with letrozole: a case report and implications of biomarkers on treatment selection M Ozdogan, M Samur, HS Bozcuk, E Sagtas, M Yildiz, M Artac, B Savas Japanese journal of clinical oncology 33 (5), 229-231, 2003 | 59 | 2003 |
| Prognostic significance of p53 in gastric cancer: a meta-analysis M Yildirim, V Kaya, O Demirpence, S Gunduz, H Bozcuk Asian Pacific Journal of Cancer Prevention 16 (1), 327-332, 2015 | 56 | 2015 |
| Cisplatin cytotoxicity is enhanced with zoledronic acid in A549 lung cancer cell line: Preliminary results of an in vitro study OH Ozturk, H Bozcuk, D Burgucu, D Ekinci, M Ozdogan, S Akca, M Yildiz Cell biology international 31 (9), 1069-1071, 2007 | 56 | 2007 |
| Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study … J Gligorov, B Ataseven, M Verrill, M De Laurentiis, KH Jung, HA Azim, ... European Journal of Cancer 82, 237-246, 2017 | 51 | 2017 |
| Predictors of distant metastasis at presentation in breast cancer: a study also evaluating associations among common biological indicators H Bozcuk, G Uslu, E Peştereli, M Samur, M Ozdoğan, Ş Karaveli, F Sargın, ... Breast cancer research and treatment 68, 239-248, 2001 | 51 | 2001 |
| Fundamental principals of tumor necrosis factor-alpha gene therapy approach and implications for patients with lung carcinoma AD Sanlioglu, C Aydin, H Bozcuk, E Terzioglu, S Sanlioglu Lung cancer 44 (2), 199-211, 2004 | 47 | 2004 |
| Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a … D Miles, E Ciruelos, A Schneeweiss, F Puglisi, T Peretz-Yablonski, ... Annals of Oncology 32 (10), 1245-1255, 2021 | 46 | 2021 |
| Gene methylation of SFRP2, P16, DAPK1, HIC1, and MGMT and KRAS mutations in sporadic colorectal cancer S Pehlivan, M Artac, T Sever, H Bozcuk, C Kilincarslan, M Pehlivan Cancer genetics and cytogenetics 201 (2), 128-132, 2010 | 42 | 2010 |
| Quality of life in patients with advanced non-small cell lung cancer H Bozcuk, B Dalmis, M Samur, M Ozdogan, M Artac, B Savas Cancer Nursing 29 (2), 104-110, 2006 | 42 | 2006 |
Mustafa Özdoğan, MDTıbbi Onkoloji, Memorial Sağlık Grubumemorial.com.tr üzerinde doğrulanmış e-posta adresine sahip
